Synthetic antibody patent awarded to PHI by Japan
Phase Holographic Imaging AB (PHI) announces today that the Company has been granted a patent concerning synthetic antibodies in Japan. The corresponding US patent was granted in 2020. “With granted patents, we are on track to secure a patent family that can lead to new screening methods for diagnosing cancer at an early stage. The grants in the US and Japan, together with the prospect of grants in Europe and China as well, prompt us to consider how we best commercialize the intellectual property rights”, says Peter Egelberg, CEO of PHI. PHI submitted the granted patent